JP Morgan Chase’s SPDR S&P International Health Care Sector IRY Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2016
Q1
Sell
-37,045
Closed -$1.87M 5281
2015
Q4
$1.87M Buy
37,045
+105
+0.3% +$5.21K ﹤0.01% 2792
2015
Q3
$1.79M Buy
36,940
+4,300
+13% +$225K ﹤0.01% 2803
2015
Q2
$1.67M Buy
32,640
+8,990
+38% +$477K ﹤0.01% 3006
2015
Q1
$1.22M Buy
23,650
+18,826
+390% +$938K ﹤0.01% 3124
2014
Q4
$226K Sell
4,824
-8,857
-65% -$423K ﹤0.01% 3992
2014
Q3
$671K Buy
13,681
+94
+0.7% +$4.57K ﹤0.01% 3537
2014
Q2
$671K Buy
13,587
+535
+4% +$25.5K ﹤0.01% 3016
2014
Q1
$611K Buy
13,052
+5,769
+79% +$266K ﹤0.01% 3066
2013
Q4
$326K Buy
+7,283
New +$313K ﹤0.01% 3648

Other funds holding IRY

JP Morgan Chase's IRY Position: Q1 2016 in Review

JP Morgan Chase sold out of SPDR S&P International Health Care Sector (IRY) in Q1 2016, closing a stake of 37,045 shares — an estimated $1.87M sold.

JP Morgan Chase first reported a position in IRY in Q4 2013 and held it in 9 quarters. The position peaked at $1.87M in Q4 2015. 22 funds tracked by Wall St. Rank hold IRY as of Q1 2016.

  • JP Morgan Chase reported no remaining SPDR S&P International Health Care Sector position as of Q1 2016 after selling out during the quarter.
  • JP Morgan Chase sold 37,045 SPDR S&P International Health Care Sector shares in Q1 2016, an estimated $1.87M.
  • JP Morgan Chase first reported a position in SPDR S&P International Health Care Sector in Q4 2013 and held it in 9 quarters.
  • JP Morgan Chase's SPDR S&P International Health Care Sector position peaked at $1.87M in Q4 2015.
  • 22 funds tracked by Wall St. Rank held SPDR S&P International Health Care Sector as of Q1 2016.

Based on JP Morgan Chase's 13F filing for Q1 2016, filed 10 May 2016.